BEHAVIORAL PHARMACOLOGICAL PROFILE OF CGS-9895 - A NOVEL ANXIOMODULATOR WITH SELECTIVE BENZODIAZEPINE AGONIST AND ANTAGONIST PROPERTIES

被引：29
|
作者：
BENNETT, DA
AMRICK, CL
WILSON, DE
BERNARD, PS
YOKOYAMA, N
LIEBMAN, JM
机构：
来源：
DRUG DEVELOPMENT RESEARCH | 1985年 / 6卷 / 04期
关键词：
D O I：
10.1002/ddr.430060404
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：313 / 325
页数：13
相关论文
共 50 条
  • [31] Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist
    Arai, Kiyoshi
    Homma, Tsuyoshi
    Morikawa, Yuka
    Ubukata, Naoko
    Tsuruoka, Hiyoyuki
    Aoki, Kazumasa
    Ishikawa, Hirokazu
    Mizuno, Makoto
    Sada, Toshio
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 761 : 226 - 234
  • [32] PHARMACOLOGICAL PROFILE OF DA-8010, A NOVEL BLADDER SELECTIVE MUSCARINIC RECEPTOR 3 ANTAGONIST FOR TREATMENT OF OVERACTIVE BLADDER
    Lee, Min Jung
    Moon, Jun-Hwan
    Park, Hyun-Min
    Lee, Hyung Keun
    Cho, Jong Hwan
    Choi, Sung Hak
    Im, Weonbin
    JOURNAL OF UROLOGY, 2016, 195 (04): : E416 - E417
  • [33] The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties
    Sugidachi, A
    Asai, F
    Ogawa, T
    Inoue, T
    Koike, H
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (07) : 1439 - 1446
  • [34] Pharmacological properties of ASP7657, a novel, potent, and selective prostaglandin EP4 receptor antagonist
    Kazuhiko Mizukami
    Hiroaki Kamada
    Hiroyuki Yoshida
    Ikuko Ishii
    Eisuke Nozawa
    Koichi Wada
    Tohru Ugawa
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2018, 391 : 1319 - 1326
  • [35] Pharmacological properties of ASP7657, a novel, potent, and selective prostaglandin EP4 receptor antagonist
    Mizukami, Kazuhiko
    Kamada, Hiroaki
    Yoshida, Hiroyuki
    Ishii, Ikuko
    Nozawa, Eisuke
    Wada, Koichi
    Ugawa, Tohru
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 (12) : 1319 - 1326
  • [36] In vitro and in vivo pharmacological profile of UFP-512, a novel selective δ-opioid receptor agonist;: correlations between desensitization and tolerance
    Aguila, B.
    Coulbault, L.
    Boulouard, M.
    Leveille, F.
    Davis, A.
    Toth, G.
    Borsodi, A.
    Balboni, G.
    Salvadori, S.
    Jauzac, P.
    Allouche, S.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (08) : 1312 - 1324
  • [37] In vitro and in vivo pharmacological profile of MGS0039, a novel potent and selective antagonist of group II metabotropic glutamate receptor
    Yoshikawa, R
    Okuno, S
    Shimazaki, T
    Yasuhara, A
    Okuyama, S
    Nakazato, A
    Nakanishi, S
    Chaki, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 165P - 165P
  • [38] Pharmacological profile of a selective 5-HT1A receptor antagonist with procognitive properties in nonhuman primates: SRA-333
    Schechter, LE
    Smith, DL
    Rosenzweig-Lipson, S
    Sukoff, S
    Dawson, LA
    Marquis, K
    Jones, DE
    Piesla, M
    Andree, T
    Harder, J
    Womack, MD
    Buccafusco, J
    Terry, AV
    Rada, P
    Kelly, M
    Abou-Gharbia, MA
    Barrett, JE
    Childers, W
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S291 - S291
  • [39] Navacaprant, a novel and selective kappa opioid receptor antagonist, has no agonist properties implicated in opioid-related abuse
    Morrison, Filomene G.
    Van Orden, Lori Jean
    Zeitz, Karla
    Kuijer, Eloise J.
    Smith, Sharon L.
    Heal, David J.
    Wallace, Tanya L.
    NEUROPHARMACOLOGY, 2024, 257
  • [40] Pharmacological properties of A-204176, a novel and selective α1A adrenergic agonist, in in vitro and in vivo models of urethral function
    O'Neill, AB
    Buckner, SA
    Brune, ME
    Milicic, I
    Daza, AV
    Gauvin, DM
    Altenbach, RJ
    Meyer, MD
    Williams, M
    Sullivan, JP
    Brioni, JD
    LIFE SCIENCES, 2001, 70 (02) : 181 - 197
12345